![]() |
Volumn 69, Issue 3, 2001, Pages 1593-1598
|
Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MEMBRANE PROTEIN PSPA;
PNEUMOCOCCUS VACCINE;
RECOMBINANT PROTEIN;
RECOMBINANT PROTEIN SP101;
RECOMBINANT PROTEIN SP128;
RECOMBINANT PROTEIN SP130;
RECOMBINANT PROTEIN SP36;
RECOMBINANT PROTEIN SP46;
RECOMBINANT PROTEIN SP91;
UNCLASSIFIED DRUG;
VIRULENCE FACTOR;
ANIMAL CELL;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
GENE ISOLATION;
GENE SEQUENCE;
GENE TARGETING;
INFECTION PREVENTION;
MOUSE;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
OPEN READING FRAME;
PRIORITY JOURNAL;
STREPTOCOCCUS PNEUMONIAE;
VACCINATION;
AMINO ACID SEQUENCE;
ANIMALS;
ANTIGENS, BACTERIAL;
BACTERIAL VACCINES;
CONSERVED SEQUENCE;
CONVALESCENCE;
FEMALE;
GENOMICS;
HUMANS;
MICE;
MICE, INBRED C3H;
MOLECULAR SEQUENCE DATA;
PNEUMOCOCCAL INFECTIONS;
PNEUMOCOCCAL VACCINES;
SEPSIS;
SEROTYPING;
STREPTOCOCCUS PNEUMONIAE;
TECHNOLOGY, PHARMACEUTICAL;
|
EID: 0035114563
PISSN: 00199567
EISSN: None
Source Type: Journal
DOI: 10.1128/IAI.69.3.1593-1598.2001 Document Type: Article |
Times cited : (308)
|
References (28)
|